Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 59

J-Pharma takes in $16.3m

Osaka University Venture Capital was among the investors in a series D round for Kyorin University-founded cancer treatment developer J-Pharma.

Jul 30, 2020

Ceros captures $100m

The cloud-based design platform has raised $100m from new and existing shareholders, but it is unclear if CNF Investments was among those that returned.

Jul 27, 2020

Corporate venturing deal net: 20-24 July 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jul 24, 2020

Scalable Capital mounts $58m series D campaign

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

Jul 23, 2020

Encoded embeds $135m in series D round

GV had led an oversubscribed series D round for the gene therapy developer that also featured Illumina Ventures and SoftBank Vision Fund II.

Jul 23, 2020

Scalable Capital mounts $58m series D campaign

Scalable Capital is valued in excess of $460m following a Tengelmann-backed round that lifted the digital wealth manager's total funding to about $130m.

Jul 23, 2020

Corporate venturing deal net: 13-17 July 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jul 17, 2020

Coatue comes to Vedantu with $100m

TAL Education-backed online tutoring service Vedantu's Coatue-led series D round increased its valuation from $280m to $600m.

Jul 17, 2020

Litte Bear feeds on series D1 funding

IT equipment provider Little Bear Rental will upgrade its partnership with JD.com following the round, where it raised a nine-digit renminbi amount.

Jul 17, 2020

Pfizer buys into BioAtla's series D round

Pfizer Ventures, billed as an existing investor, contributed to the $72.5m close of the antibody-drug conjugate developer's latest round.

Jul 16, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here